Who should receive obesity medicines?

1.3 million Swedes have been diagnosed with obesity or are at risk of becoming obese. Obesity often leads to a range of complications such as diabetes, high blood pressure, and joint and heart problems. Despite this, none of the new effective drugs such as ozempic for the treatment of obesity are subsidized in Sweden. If you want to access that medicine or something similar to try to lose weight by reducing your hunger hormones, you have to finance it yourself.

Read more 

Contact us

Environment and Public Health Institute


Box 3039,
103 63 Stockholm

info@ephi.se

Org. number: 559342-4947

Latest from ephi.se on TT

Podcast: Health for the unhealthy

224. Everything About Gut Flora

Gut bacteria have been linked to everything from obesity to depression, but how much do we really know? Gianluca Tognon, associate professor of public health science at the University of Skövde and leader of the MIND-GUT study, explains what the research says about the connection between the gut and the rest of the body...

read more

223. Longevity for Everyone

Can we build a society that not only treats illness but also helps us stay healthy longer? EPHI CEO Marie Söderqvist discusses the report ”From Health Care to Wellness—How Longevity Strengthens Public Health and the Economy.” We discuss how preventive care,...

read more

220. Sweden's COVID-19 Strategy

Johan Carlson, former Director General of the Public Health Agency of Sweden during the COVID-19 pandemic and author of the book *Vi mot världen* (Us Against the World), discusses Sweden’s strategy and the reactions of the international community. 

read more